Delisted

Stopped trading. Fund positions aren't valued until we confirm what happened.

45

INTERCEPT PHARMACEUTICALS IN

45845PAC2Bond

45845PAC2 (INTERCEPT PHARMACEUTICALS IN) is held by 0 institutional investors as of Q4 2023.

Top Holders

Fund ownership
Fund holdings as of
Funds holding0
Value of reported holdings$0
Funds buying / selling
Not available

No holders found

No institutional holders are currently tracking this security.

Loading insider trades…
Loading Congress trades…
Loading activist filings…

Questions investors ask about 45845PAC2

Who owns INTERCEPT PHARMACEUTICALS IN?

0 institutional investors held INTERCEPT PHARMACEUTICALS IN on December 31, 2023, according to their 13F filings.

How many hedge funds hold INTERCEPT PHARMACEUTICALS IN?

0 institutional investors reported INTERCEPT PHARMACEUTICALS IN in their 13F filings for the quarter ended December 31, 2023.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Optional analytics helps us improve. How it’s used